Executive-Level Program: Achieving Disruptive Innovation: Four Perspectives
There are many challenges confronting innovation in pharma and healthcare. With drug development costs and the costs of healthcare, biopharmaceutical companies and healthcare systems are trapped between the pressure to reduce development costs and the need to ensure better outcomes and provide enhanced value for patients, all while continuing to innovate and to manage the complexity of clinical trials.
New technologies will drive innovation in the pharmaceutical and healthcare industries in the years to come. Unlike other industries, the “Uber” of the life science industry has yet to emerge and the market remains ripe for digital disruption. The ability to disruptively innovate will be a critical factor in pharmaceutical and healthcare industries’ success in the future. Companies will have to embrace scientific advances, new processes and technologies to move new and innovative therapies forward.
Join us for this informative session featuring a panel of four experts on technology in the pharmaceutical and healthcare industries.
Agenda
7:00 - 7:30 AM Register, networking and breakfast
7:30 - 7:45 AM Opening and introductions
7:45 - 8:45 AM Panel session
8:45 - 9:00 AM Q & A and close
Special instructions: Park in location with HBA signs.
Registration information
Event is open to: HBA members and nonmembers
Online registration deadline: 11 September 2018
Onsite (walk-in) registration: Is NOT allowed
This event is refundable. All refund requests must be submitted in writing to events@hbanet.org by 19 September 2018. No refunds are available after this date.
Learning Objectives
1. Describe how one can set strategy in a world that is changing so rapidly, and what do you do when what you
know is vastly outweighed by what you don't know.
2. Develop an approach of experimenting to innovate - how to cultivate a "fail smart, learn fast" philosophy.
3. Identify how to care for employees and retain customers during disruptive change.
Featured Speakers
Georgia
Papathomas
Senior vice president and global head of data analytics,
Johnson & Johnson
Pricing
| 1 - Regular registration | $75.00 / €64.00 | $115.00 / €98.00 |
| 2 - Novartis employees | | $75.00 / €64.00 |
Members receive up to 50 percent discount
Event Policies
Photography Policy
By registering for this event, you acknowledge that you may be photographed, videotaped, and/or audio-taped during the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion, and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.
COVID-19 Policy
The HBA requires that all persons who participate in in-person events do so at their own risk and that each participant agrees to the following agreement before taking part in the activity and urges all participants to act in such a manner as to protect their own safety and the safety of others.
By registering for this event, I fully understand that my participation in the program is purely voluntary. I desire to participate and agree to act reasonably and prudently under the circumstances. I further understand that any HBA volunteers participating in the activity will act individually and will not represent the HBA. As a condition to my participation the activity, I waive and release the HBA and their officers, employees, and agents from any claim that I may have for any damage to property or injury to my person that may result in whole or in part from my participation.
Special Needs Policy
The HBA will make reasonable modifications to policies and programs to ensure that people with special needs can enjoy all of its programs. Contact us if you require special accommodations for this event.